TONGRENTANGCM
036135.4650.36% ( -0.020 )
Delay Closed: Nov 13, 16:08:17News
Biotech Breakthroughs and Tech Restructurings Drive Hong Kong Small-Cap Divergence
Global Report·- Hong Kong small-cap stocks showed a divergent trend recently, driven by regulatory changes and strategic adjustments. - Biotech firms like JW Cayman Therapeutics saw a 15.4 % weekly gain after entering national medical insurance negotiations, while tech companies experienced mixed performances. - This market fluctuation reflects small-cap enterprises' adaptive restructuring amid shifting regulatory environments and broader economic uncertainties.